Moleculin Biotech MBRX
NASDAQ MBRX
$0.53 -0.04 (-7.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Acquisitions (2016)

Updated

Moleculin Biotech (MBRX) reported Acquisitions of $100,000 for FY2016.

Analysis

Moleculin Biotech (MBRX) Acquisitions (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Moleculin Biotech 3.24 Mn 3.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 99,638.00
API Access

Moleculin Biotech Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=MBRX&period=max&api_key=YOUR_API_KEY